Introduction {#sec1-1}
============

Diabetes is a very common chronic endocrinological disease which is characterized by hyperglycemia.\[[@ref1][@ref2]\] In 2017, estimated 8.8% of the adult population worldwide were diabetics.\[[@ref3]\] Most patients were aged above 60 years and prominent in countries classified high-income countries. However, in low- and middle-income countries, most patients were at age 40--60 years old. Whiting *et al*. expected that there will be a rise to 522 million people with diabetes in 2030.\[[@ref4]\] The Middle East and North Africa appear to have the highest comparative prevalence of diabetes at 11%. A total of 6 Arabic countries are in the top 10 countries with highest prevalence of diabetes: Kuwait (21.1%), UAE (19.2%) Saudi Arabia (20%), Bahrain (19.9%), and Qatar (20.2%). For 20 Arabic countries, there are more than 20.5 million people are diabetic, and 13.7 million have impaired glucose tolerance, prediabetic. Diabetes attribute to about 170,000 deaths, which represent 10% of all death in the Arabic region.\[[@ref5]\] Diabetic retinopathy is a common complication of diabetes. Itconstitutes 4.8% of the global causes of blindness. Diabetic retinopathy is a silent disease, early detection and intervention is essential for its management and prognosis.\[[@ref6]\]

Despite the high literacy levels and various health programs for diabetes, there is a continuous increase in diabetes prevalence and its complications. It is recognized that more than 77% of patients who survive for over 20 years with diabetes are affected by retinopathy.\[[@ref7]\] It is estimated that 10.2 million US adults 40 years and older known to have diabetes, the estimated prevalence rate for developing diabetic retinopathy was 40.3%.\[[@ref8]\] The prevalence of diabetic retinopathy in different regions of Saudi Arabia: Riyadh (31%), Madinah (36.8%), Taif (36.1%), and Al-Hassa (30%).\[[@ref7]\] In 2007, a study conducted in Oman to assess the perception and the awareness of population showed that the knew of diabetes was suboptimal, only 57% knew the classic symptoms, and 55% know the complications of diabetes.\[[@ref9]\] In 2012, a cross-sectional survey study conducted in Riyadh, Saudi Arabia showed that the awareness of diabetes complications was suboptimal, diabetic nephropathy the most frequently mentioned complications. Only 44%, 43%, 42%, and 31% recognized blindness, stroke, diabetic neuropathy, and gangrene, respectively, as a complication of diabetes.\[[@ref10]\] This study aims to assess the level of awareness for diabetic eye disease among diabetic patients.

Materials and Methods {#sec1-2}
=====================

This is a cross-sectional community-based study was conducted in Saudi Arabia from the period between June and September 2018 to assess the awareness level of diabetic Saudi citizens about diabetic retinopathy and its complications. The study included all diabetic Saudi participants between 15 and 75 years of age, regardless of their type of diabetes and the duration of the disease.

The population is almost 2 million according to Saudi General Authority for Statistics. The minimal sample size that can represent the population is 385, by considering the margin of error of 5% and confidence level is 95%. A total of 400 surveys were distributed and the overall response rate was 96%.

A previously validated questionnaire was used in the study.\[[@ref11]\] The questionnaire was distributed directly to the participants in Riyadh, Saudi Arabia public facilities. The questionnaire included informed consent, demographic data, health status, the type of DM, the duration of the disease, and their level of control. The second part included several questions to assess the participants' awareness ofdiabetes retinopathy complications and treatment.

Statistical analysis {#sec2-1}
--------------------

Microsoft Excel was used for data entry, and SPSS version 22.0 (Armonk, NY: IBM Corp) was used for data analysis. Descriptive statistics was used to assess the baseline demographics, participants' diabetic control which was presented as frequencies and percentages. Mean and the standard deviation were calculated for participants' age only. Chi-square was used to assess and to compare between genders and between participants control level. Any test with *P* value was less than 0.05 was considered statistically significant.

Results {#sec1-3}
=======

This study involved 385 Saudi participants with an average age of the participants was 47.82 ± 14.49. The ratio between male and female participants was almost equal (190 males, 195 females). The study only involved patients who were diagnosed with type 1 DM or 2 DM. And 81% of the sample was diagnosed with type 2 DM. Regarding the disease duration, 173 (44.9%) were diagnosed with diabetes mellitus \<5 years, 122 (31.7%) between 6 and 10 years and 90 (23.4%) for more than 11 years. The participants' baseline characteristics were presented in [Table 1](#T1){ref-type="table"}.

###### 

Baseline of the participants

  -------------------- ------------------- -------------
  Age                  Mean±SD             47.82±14.49
  Gender               Male                190 (49.4)
  Female               195 (50.6)          
  Level of education   Illiterate          8 (2.1)
  Low education        96 (24.9)           
  University           248 (64.4)          
  High education       33 (8.6)            
  Type of DM           Type 1              72 (18.7)
  Type 2               313 (81.3)          
  DM control           Good                99 (25.5)
  Intermediate         186 (48.3)          
  Poor                 101 (26.2)          
  Duration of DM       Less than 5 years   173 (44.9)
  6-10 years           122 (31.7)          
  11-20 years          64 (16.6)           
  More than 20 years   26 (6.8)            
  Health state         Dyslipidemia        182 (47.3)
  HTN                  100 (26)            
  MI                   29 (7.5)            
  -------------------- ------------------- -------------

HTN=Hypertension, MI=Myocardial infraction

The participant response according to their gender was presented in [Table 2](#T2){ref-type="table"}. There were no significant differences between male and female in almost all variables. However, when it comes to the treatment of diabetic retinopathy, female participants were more likely to choose good control of blood glucose and photocoagulation as the main treatment (*P* = 0.01). The participant response according to their blood glucose control was shown in [Table 3](#T3){ref-type="table"}. There was a remarkable variation between groups regarding the participants' opinion toward the need for eye screening in diabetic patients with good control.

###### 

Participants response according to their gender

                                                                   Male         Female       P
  -------------------------------------------- ------------------- ------------ ------------ --------
  DM affect the eye with good control          Yes                 80 (42.1)    62 (31.8)    0.05
  No                                           40 (21.1)           59 (30.2)                 
  I don't know                                 70 (36.8)           74 (38)                   
  The need for eye screening in poor control   Yes                 140 (73.7)   138 (70.8)   0.81
  No                                           9 (4.7)             10 (5.1)                  
  I don't know                                 41 (21.6)           47 (24.1)                 
  CAD as complication of DM                    Yes                 85 (44.7)    90 (46.1)    0.95
  No                                           27 (14.2)           28 (14.4)                 
  I don't know                                 78 (41.1)           77 (39.5)                 
  Stroke as complication of DM                 Yes                 83 (43.7)    89 (45.6)    0.91
  No                                           30 (15.8)           31 (15.9)                 
  I don't know                                 77 (40.5)           75 (38.5)                 
  PAD as complication of DM                    Yes                 61 (32.1)    59 (30.3)    0.78
  No                                           32 (16.8)           38 (19.5)                 
  I don't know                                 97 (51.1)           98 (50.3)                 
  Neuropathy as complication of DM             Yes                 104 (54.7)   114 (58.5)   0.72
  No                                           31 (16.3)           31 (15.9)                 
  I don't know                                 55 (29)             50 (25.6)                 
  Retinopathy as complication of DM            Yes                 144 (75.8)   153 (78.5)   0.77
  No                                           18 (9.5)            15 (7.7)                  
  I don't know                                 28 (14.7)           27 (13.8)                 
  Nephropathy as complication of DM            Yes                 112 (58.9)   133 (68.2)   0.16
  No                                           26 (13.7)           22 (11.3)                 
  I don't know                                 52 (27.4)           40 (20.5)                 
  Source of knowledge                          Doctor              86 (45.3)    87 (44.6)    0.97
  Family                                       40 (21)             43 (22.1)                 
  Media                                        33 (17.4)           36 (18.5)                 
  Don't know                                   31 (16.3)           29 (14.9)                 
  Treatment of DM retinopathy                  Good control        39 (20.5)    53 (27.2)    0.01\*
  Laser                                        28 (14.7)           46 (23.6)                 
  Surgery                                      26 (13.7)           14 (7.2)                  
  Don't know                                   97 (51.1)           82 (42)                   
  Reason for not screening                     Lack of knowledge   96 (50.5)    90 (46.1)    0.35
  Distance                                     51 (26.8)           53 (27.2)                 
  Financial reasons                            26 (13.7)           26 (13.3)                 
  Lack of time                                 12 (6.3)            12 (6.2)                  
  Afraid of the results                        5 (2.6)             14 (7.2)                  

DM=Diabetes mellitus, CAD=Coronary artery disease, Data presented as n (%), P \< 0.05 is statistically significant

###### 

Participants response according to their blood glucose control

  DM control                                   Response            Good (N.98)   Intermediate (N.186)   Poor (N.101)   *P*
  -------------------------------------------- ------------------- ------------- ---------------------- -------------- ------------
  DM affect the eye with good control          Yes                 48 (49)       65 (35)                29 (28.7)      0.005\*
  No                                           28 (28.6)           46 (24.7)     25 (24.8)                             
  I don't know                                 22 (22.4)           75 (40.3)     47 (46.5)                             
  The need for eye screening in poor control   Yes                 81 (82.7)     139 (74.7)             58 (57.4)      \<0.0001\*
  No                                           7 (7.1)             6 (3.3)       6 (5.9)                               
  I don't know                                 10 (10.2)           41 (22)       37 (36.6)                             
  CAD as complication of DM                    Yes                 50 (51)       85 (45.7)              40 (39.6)      0.022\*
  No                                           17 (17.4)           17 (9.1)      21 (20.8)                             
  I don't know                                 31 (31.6)           84 (54.2)     40 (39.6)                             
  Stroke as complication of DM                 Yes                 46 (46.9)     87 (46.8)              39 (38.6)      0.34
  No                                           19 (19.4)           24 (12.9)     18 (17.8)                             
  I don't know                                 33 (33.7)           75 (49.3)     44 (43.6)                             
  PAD as complication of DM                    Yes                 33 (33.7)     62 (33.3)              25 (24.8)      0.03\*
  No                                           20 (20.4)           23 (32.9)     27 (26.7)                             
  I don't know                                 45 (45.9)           101 (54.3)    49 (48.5)                             
  Neuropathy as complication of DM             Yes                 63 (64.3)     110 (59.2)             45 (44.5)      0.61
  No                                           14 (14.3)           27 (14.5)     21 (20.8)                             
  I don't know                                 21 (21.4)           49 (26.3)     35 (34.7)                             
  Retinopathy as complication of DM            Yes                 80 (81.6)     152 (81.7)             65 (64.4)      0.004\*
  No                                           10 (10.2)           11 (5.9)      12 (11.9)                             
  I don't know                                 8 (8.2)             23 (12.4)     24 (23.8)                             
  Nephropathy as complication of DM            Yes                 66 (67.4)     134 (72)               45 (44.5)      \<0.0001\*
  No                                           12 (12.2)           14 (7.5)      22 (21.8)                             
  I don't know                                 20 (20.4)           38 (20.5)     34 (33.7)                             
  Source of knowledge                          Doctor              52 (53.1)     72 (38.7)              49 (48.5)      \<0.0001\*
  Family                                       20 (20.4)           45 (24.2)     18 (17.8)                             
  Media                                        15 (15.3)           47 (25.3)     7 (6.9)                               
  Don't know                                   11 (11.2)           22 (11.8)     27 (26.8)                             
  Treatment of DM retinopathy                  Good control        31 (31.6)     46 (24.7)              15 (14.8)      0.003\*
  Laser                                        20 (20.4)           38 (20.4)     16 (15.8)                             
  Surgery                                      16 (16.3)           14 (7.5)      10 (9.9)                              
  Don't know                                   31 (31.6)           88 (47.3)     60 (59.4)                             
  Reason for not screening                     Lack of knowledge   46 (46.9)     89 (47.9)              51 (50.5)      0.98
  Distance                                     28 (28.6)           50 (26.8)     26 (25.7)                             
  Financial reasons                            11 (11.2)           28 (15.1)     13 (12.9)                             
  Lack of time                                 7 (7.1)             10 (5.4)      7 (6.9)                               
  Afraid of the results                        6 (6.1)             9 (4.8)       4 (4)                                 

DM=Diabetes mellitus, CAD=Coronary artery disease, Data presented as N (%), *P*\<0.05 is statistically significant

Moreover, 59% of the participant with good controlled blood glucose believed in the necessity of diabetic retinopathy screening even with controlled blood glucose. Whereas only 29.7% of the poorly controlled group, think there is a need to screen the eye with good control (*P* \< 0.0001). When patients were asked about the reason for not screening, the majority chose poor knowledge and lack of awareness as the main factor (*P* = 0.98). On the subject of the source of participants' knowledge of DM and its complication, there was a notable difference between groups. For instance, 38% of the intermediate controlled group considered the doctor as the mainsource, while 25% of the same group obtained their information from the media. However, 53% of the well-controlled group received their information from their physician, and 20% assume the family member as the primary source.

Discussion {#sec1-4}
==========

In the present study, the mean age of patients was 47.82 years old, there were 50.6% females and the large majority 81.3% had type 2 DM, there were only 25.5% reported good control for diabetes and 6.8% reported having DM more than 20 years and the most reported health problem was dyslipidemia 47.3%. Regarding the knowledge of patients, there were 311 (80.8%) knew that DM affect the eyes, and only 99 (25.7%) denied that DM affect the eye with good control. There were 184 (48.8%) agree that eye screening is needed in good control, and 278 (72.2%) reported it is needed in poor control. There were 175 (45.5%) reported that coronary artery disease is a complication of DM, 172 (44.7%) reported stroke, 120 (31.2%) reported peripheral artery disease (PAD), 218 (56.6%) reported neuropathy, 297 (77.1%) reported retinopathy and 245 (63.6%) reported nephropathy.

A previous study from Saudi Arabia showed that 82.6% of patients were aware that DM could affect the eye.\[[@ref12]\] Another study from Jordan\[[@ref13]\] reported that 88.2% of patients knew that DM could affect the eye. Another Jordanian study\[[@ref14]\] found that 98.3% of patients knew that DM could affect their eyes, and only 50.4% reported being familiar to retinopathy. A study from South Africa showed that 66.1% of participants were aware of visual threats caused by DM and 42% only knew that DM could result in diabetic retinopathy.\[[@ref15]\] Regarding the source of information among our patients, the most reported source was a doctor 44.9% followed by family and media 21.6% and 17.9%, respectively. Regarding the treatment of DM retinopathy, there was bad knowledge where 23.9% reported good control, 19.2% reported laser, 10.4% reported surgery, and most of the 46.5% said they did not know. The most common sources of information reported by previous Saudi study\[[@ref12]\] were physicians 37%, family members 11%, and someone with DM 9%, where as general practitioners 47.3% were the main source of knowledge in Jordanian study.\[[@ref13]\] The most reported reason for first eye screening of our patients was doctor 74.8%, and the most common reason for not screening was lack of knowledge 48.3%, whereas in Jordanian study\[[@ref13]\] it was demonstrated that lack of information about diabetic retinopathy was the most common barrier 44% for eye screening. Another study\[[@ref14]\] demonstrated that 33.9% reported that the barrier prevents them from getting eye screening was lack of knowledge about diabetic retinopathy.

Conclusion {#sec1-5}
==========

There was an acceptable level of knowledge among patients. However, some points of knowledge should be increased. Female patients and those with intermediate and good control tend to have more knowledge among the other patients.
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